Increased Viability of Fibroblasts When Pretreated with Ceria Nanoparticles During Serum Deprivation [Corrigendum]
Genier FS, Bizanek M, Webster TJ, Roy AK. Int J Nanomedicine. 2018;13: 895–901.
The authors have advised the author and affiliation list on page 895 are incorrect. The correct author list and affiliations are as follows.
Francielli S Genier1
Thomas J Webster1,3
Amit K Roy1,3
1Department of Chemical Engineering, Northeastern University, Boston, MA, USA; 2Biological Sciences, Northeastern University, Boston, MA, USA; 3Wenzhou Institute of Biomaterials and Engineering (WIBE), Wenzhou University,Wenzhou, People’s Republic of China
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]